Zealand Pharma
The Scientist I/II will independently design, execute, analyze, and interpret complex in vivo rodent studies to support compound screening and pharmacology profiling for novel therapeutics targeting obesity and metabolic diseases. The role involves hands‑on drug administration, sample collection, data analysis, and cross‑functional collaboration with internal and external partners.
Headquarters
Søborg, Hovedstaden, Denmark
Company Size
201-500 employees
Founded
1998
N/A
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Zealand Pharma.
Zealand Pharma didn’t post a salary, so this is our estimate from similar listings.
26% below the average for this role
Scientist III/ IV, In Vivo - Cardiometabolic - Chronic Kidney Disease
Digital Biology
Senior Scientist, In Vivo Metabolism Bioscience
AstraZeneca
Director of In Vivo Pharmacology
Flagship Pioneering, Inc.
Research Associate
Novo Nordisk A/S
Advisor – In vivo pharmacologist – Cardiometabolic Research
Eli Lilly and Company
Scientist
ASTARPRD